SCHEMBL29116493

SCHEMBL29116493

C[C@@H](O)[C@H](N)C(=O)Nc1ncnc2c1ncn2C(N)=O

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 1/20 0.36
▸ TARS1 P26639 2/20 0.35
▸ YTHDC1 Q96MU7 1/20 0.35
▸ CCNB2 O95067 2/20 0.34
▸ CDK1 P06493 2/20 0.34
▸ CCNB1 P14635 2/20 0.34
▸ CCNB3 Q8WWL7 2/20 0.34
▸ ADORA1 P30542 5/20 0.34
▸ ADORA3 P0DMS8 4/20 0.34
▸ FGFR1 P11362 2/20 0.33
▸ FGFR4 P22455 2/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ SPHK1 Q9NYA1 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Threonine SCHEMBL28960545 0.83 YTHDC1 (0.45) YTHDC1ADORA1ADORA3ADORA2A
SCHEMBL26603870 0.80 ADORA2A (0.34) ADORA1ADORA3ADORA2ASPHK1
SCHEMBL29002283 0.75 CYP1A2 (0.36) GSK3BADORA1ADORA2A
SCHEMBL29184339 0.72 SPHK1 (0.36) TARS1SPHK1
SCHEMBL29047902 0.72 ADORA2A (0.60) ADORA2A
SCHEMBL29047905 0.72 ADORA2A (0.60) ADORA2A
SCHEMBL16987222 0.71 TARS1 (0.38) TARS1ADORA1
SCHEMBL5155877 0.71 TARS1 (0.62) TARS1ADORA1
SCHEMBL31326251 0.71 TARS1 (0.36) TARS1ADORA1ADORA3ADORA2A
SCHEMBL28300819 0.71 ADORA3 (0.35) TARS1ADORA1ADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118697900-A Method for preparing lipid nanoparticles 摩登纳特斯有限公司 2024-09-27 — — CN disclosed
CN-118076741-A Modified mRNA, modified non-coding RNA and uses thereof 布罗德研究所股份有限公司 2024-05-24 — — CN disclosed
CN-117159492-A Lipid nanoparticle containing sialic acid lipid derivative and application thereof 广州制高点医药科技有限公司 2023-12-05 — — CN disclosed
Send feedback